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Middle East respiratory syndrome coronavirus (MERS-CoV) is enzootic in dromedary camels
across the Middle East and Africa. Virus-induced pneumonia in humans results from animal
contact, with a potential for limited onward transmission. Phenotypic changes have been
suspected after a novel recombinant clade (lineage 5) caused large nosocomial outbreaks in
Saudi Arabia and South Korea in 2016. However, there has been no functional assessment.
Here we perform a comprehensive in vitro and ex vivo comparison of viruses from parental
and recombinant virus lineages (lineage 3, n= 7; lineage 4, n= 8; lineage 5, n= 9 viruses)
from Saudi Arabia, isolated immediately before and after the shift toward lineage 5. Repli-
cation of lineage 5 viruses is significantly increased. Transcriptional profiling finds reduced
induction of immune genes IFNB1, CCL5, and IFNL1 in lung cells infected with lineage 5 strains.
Phenotypic differences may be determined by IFN antagonism based on experiments using
IFN receptor knock out and signaling inhibition. Additionally, lineage 5 is more resilient
against IFN pre-treatment of Calu-3 cells (ca. 10-fold difference in replication). This phe-
notypic change associated with lineage 5 has remained undiscovered by viral sequence
surveillance, but may be a relevant indicator of pandemic potential.
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The pandemic spread of severe acute respiratory coronavirus2 (SARS-CoV-2) demonstrates the importance of mon-itoring emerging coronaviruses (CoV). Middle East
respiratory syndrome coronavirus (MERS-CoV) is the causative
agent of severe viral pneumonia in humans1. MERS-CoV
emerged in 2012 and the majority of currently more than 2494
notified cases, including 858 deaths, have occurred on the Ara-
bian Peninsula. Travel-associated cases were diagnosed in 27
countries and sparked secondary case clusters in some. The lar-
gest MERS-CoV outbreak outside the Arabian Peninsula occur-
red in South Korea in 2015, involving 186 cases and 36 deaths
(WHO, 2020).
MERS-CoV is acquired as a zoonotic infection from dromedary
camels2–5. Spill-over from dromedaries to humans can lead to
local outbreaks with limited human-to-human transmission6,7.
Healthcare facilities can experience protracted outbreaks with
severe infections in comorbid patients8. Behavioral factors like
family patient care may accelerate outbreaks9–11.
MERS-CoV phylogeny currently comprises three major clades,
provisionally named clades A, B, and C12–14. Whereas clades A
and C contain extinct strains and strains not circulating in the
Arabian Peninsula, clade B strains currently infect humans and
dromedary camels in this area. Clade B is subdivided into six
phylogenetic lineages. Presumed recombination between lineage 3
and 4 resulted in the formation of a circulating recombinant
lineage (lineage 5, also termed NRC for novel recombinant clade)
during or before the year 2014 in dromedary camels14–17.
Limited diagnostic testing, limited surveillance, and improved
hospital infection control may have caused an apparent decline of
notified cases after 201518. Only based on more recent studies, it
appears that lineage 5 has essentially replaced all other endemic
strains since 201519,20 (Fig. 1). Because clade B lineages used to
co-circulate widely before 2015, the novel dominance of a single
viral lineage deserves clarification. Any change of phenotype
might indicate alterations in the already existing potential for
human-to-human transmission. Changes of phenotype in asso-
ciation with lineage 5 emergence have been suspected, but phe-
notypic studies of MERS-CoV strains are generally limited.
Mutations in the spike protein positions I529T and D510G
observed during the outbreak in Korea were suggested to have
contributed to antibody evasion21. However, these polymorph-
isms evolved during and not prior to the Korean MERS-CoV
outbreak and hence cannot explain the dominance of lineage
5 since 201522. Earlier studies looking into functional differences
between MERS-CoV clades other than lineage 5 found little
evidence for phenotypic differences12,23–25. One complicating
feature of MERS-CoV is that the infection phenotype seen in
humans is difficult to reflect in small animal models.
In this work, we investigate phenotypic traits in phylogeneti-
cally distinct MERS-CoV lineages including the recombinant
lineage 5, using different cell-, epithelial-, and ex vivo human lung
models. As MERS-CoV is known to act against the induction of
cytokines and overcome the effects of antiviral genes26–30, we
investigate differences in immune gene activation and suppres-
sion of viral replication in response to interferon (IFN) signaling.
We find lineage 5 viruses replicate more efficiently, show
decreased antiviral IRF3- and NFkB-dependent signaling, and are
less susceptible to the IFN response.
Results
Phylogeny and recombination analysis of MERS-CoV isolates
obtained from Saudi Arabian patients. To facilitate a pheno-
typic comparison of MERS-CoV strains that circulated before and
after the 2014 recombination event, we generated 23 virus isolates
from patient samples obtained during outbreaks in Saudi Arabia
between 2014 and 2015 and one virus isolate obtained from a
dromedary camel farm in Dubai in 2017 using a previously
established MERS-CoV isolation protocol25. Early passage iso-
lates were grown to high concentration, physically purified, and
characterized by deep sequencing, real-time RT-PCR, and plaque
quantification. No plaque purification was performed to avoid the
introduction of selection bottlenecks. To further avoid cell
culture-derived selection biases, all quantitative experiments were
done on different representative isolates per viral clade with
subsequent pooling of results.
For phylogenetic classification, we sequenced all isolates and
inferred trees based on whole-genome sequences (Supplementary
Fig. 1). All studied isolates cluster with either lineage 3, lineage 4,
or lineage 5. As expected, lineage 5 branches from lineage 3 in a
tree based on a full genome alignment14,15,17. Among the present
isolates, seven belong to lineage 3 and originate from a MERS-
CoV outbreak in Riyadh in 201431. Eight belong to lineage 4 and
originate from a 2014 outbreak in Jeddah24. Another nine isolates
belong to lineage 5. Eight of these stem from patients treated in
Riyadh between September and November 2015, one (D896
2017) from a dromedary camel farm in Dubai sampled in 2017.
All show the typical pattern of topological incongruence when
inferring trees from alignments that cover different genome
portions relative to the two recombination breakpoints.
Replication of MERS-CoV lineages in cell culture. To compare
viral replication we performed multicycle infection experiments
in Vero B4 monkey kidney cells that are widely used for diag-
nostic isolation of MERS-CoV. We observed no significant
growth differences between isolates (Fig. 2a). Because Vero cells
are known to be deficient in IFN-I induction, we also performed
multicycle infection experiments in the human lung- and colon
carcinoma cell lines Calu-3 and Caco-2, respectively (Fig. 2b, c).
These experiments detected significantly increased replication
levels for all tested isolates pertaining to lineage 5. Growth was
enhanced over that of the EMC reference strain, but also over that
of all tested isolates pertaining to parental lineages 3 and 4
(Fig. 2a–c). Two representative isolates per lineage were tested in
these experiments initially. In order to minimize any influence of
possible inter-isolate phenotypic variability, we used an extended
range of virus isolates for the experiment in Calu-3 cells (Fig. 2b).
In each of four independent experiments, we used different sets of
two viral isolates per lineage, resulting in the representation of
each lineage by eight different viral isolates (refer to Supple-
mentary Table 1 for virus isolates used in each experimental
repetition). In addition, we infected Calu-3 cells with a lineage 5
Fig. 1 MERS-CoV sequences uploaded to NCBI GenBank between 2013
and 2020. All available GenBank entries for MERS-CoV with a sequence
length ≥28,000 nucleotides (n= 537) nucleotides were included, as well
as concatemerized sequences with sequence length ≥5,000 nucleotides19
n= 24. The collection date provided in GenBank was used for assigning a
year to each sequence. No sequences were found with a collection date
later than 2019.
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MERS-CoV isolate (D896) taken in 2017 and found this isolate to
exhibit the same replicative advantage as the 2015 lineage 5 iso-
lates (Supplementary Fig. 2). These findings indicate that the
increased replication of lineage 5 MERS-CoV may be a shared
feature of the whole phylogenetic lineage independent of time or
place of virus isolation.
On broad average, all tested isolates pertaining to lineage 5
produced viral titers at least fivefold higher at 24 hpi than lineage 3
and lineage 4 isolates (Fig. 2b, c). Within individual experiments,
representatives of lineage 5 reached up to tenfold higher infectious
titers than those of lineage 3 and 4. The experiment with multiple
replicates and isolates in Fig. 2b yielded an average concentration
of 1.23x10e5 PFU/ml for lineage 5 isolates compared to 2.2x10e4
PFU/ml for lineage 3 and 2.4x10e4 PFU/ml for lineage 4. All of
these differences were highly significant.
To better represent the conditions of viral replication in
respiratory epithelia, we infected polarized Calu-3 cells grown
under air-liquid interface (ALI) conditions and found the same
relative viral replication phenotypes (Fig. 2d).
Competitive replicative fitness. Cell culture growth kinetics can
suffer from systematic and random errors, parts of which can be
controlled for by competitive replication studies in which viral
isolates compete in the same culture dish. A given virus is likely to
have superior relative fitness if it can become dominant in a virus
population in spite of starting as a minority population in the
initial virus seed dose used for infection32. To test this, Calu-3
cells were infected with a mixture of a representative virus of
lineage 5 and lineage 3 in two different ratios (lineage 3: lineage 5
ratio, 1:1 and 9:1, respectively). The initial seed dose in these
cultures was set to 10,000 plaque-forming units (PFU), corre-
sponding to an MOI of 0.04, which enables a short multicycle
growth experiment while avoiding stochastic bottleneck effects
due to low seed dose. As the total virus amplification from a
single round of infection starting from this seed dose is too
limited to detect robust differences in replicative fitness, four
additional amplification cycles (passages) were performed. In
preliminary experiments in the given cell culture format, we
determined that the yield of infectious virus progeny when
infecting Calu-3 cells at MOI= 0.04 will be 10e4–10e5 PFU/ml at
24 hpi (Supplementary Fig. 3). We, therefore, diluted passage
supernatants to a new seed dose of ca. 5,000 PFU and repeated
this process until the completion of a total of five passages. We
isolated viral RNA from the initial inoculum (p0) and from the
supernatant after five passages (p5) and directly sequenced two
different single nucleotide polymorphisms (SNP) sites that were
each amplified from the virus population in three separate RT-
PCR reactions to control for PCR-based artifacts.
Based on Sanger sequencing we analyzed peak heights to
quantify how much of each virus lineage was present at p0 and p5
(Fig. 3a). In both analyzed positions, we found the ratio of virus
progeny at p5 to shift in favor of lineage 5 (Fig. 3b).
Analysis of stages of the viral replication cycle. Multiple factors
might be responsible for enhanced MERS-CoV growth in cell
cultures, including improved virus attachment, entry, transcrip-
tion, replication, infectious particle production, or innate immune
counteraction.
Spike protein gene sequences. We found no indications for
differences in sialic acid-binding and receptor-binding properties
in amino acid alignments of viral spike sequences (Supplementary
Fig. 4). The N-terminus mediates virus attachment via sialic acid
domains. Its sequence is identical in all four lineages and in silico
analysis by NetNGlyc and NetOGlyc showed no differences in
glycosylation patterns. The receptor-binding domain (RBD) is
responsible for binding to the entry receptor, DPP4. The four
lineages share the same amino acid sequence in the RBD, with the
exception of lineage 3 isolates showing one polymorphism
(L411F). However, previous studies of this polymorphism
demonstrated unaltered binding affinity and entry efficiency21.
Cell entry capacity and receptor binding. To explore cell entry
capacity and receptor binding, we produced expression vectors
carrying the spike genes of lineage 3, lineage 4, and lineage
5 strains and incorporated these into vesicular stomatitis virus
(VSV)-based pseudotypes21. We tested entry capacity in cell lines
expressing high and low amounts of TMRPSS2 (high: Calu-3 and
Caco-2, Fig. 4a, b; low: Huh7, Fig. 4c) to account for entry
capacity with protease-primed and non-primed spike protein33.
No differences were observed between pseudotypes.
We also expressed the lineage-specific spike proteins in
293 T cells and measured the binding capacity to the MERS-
CoV entry receptor, DPP4, by flow cytometry as described in
ref. 21. As a control, we included the previously described variant
I529T, known to have reduced binding affinity21. Again, we
found no significant differences in binding affinities between
spike proteins of each lineage (Fig. 4d).
Full virus entry studies. To investigate the entire entry process,
we performed single cycle (MOI= 1) infection assays in Calu-3
lung cells using virus isolates. We infected all cell cultures at 4 °C
to ensure that cell entry is initiated simultaneously by tempera-
ture shift to 37 °C. The onset of subgenomic N RNA (sgmRNA
N) transcription, as observable before the onset of genome
replication was taken as an early indicator of the completion of
the entry process. As a control, we simultaneously blocked the
entry of MERS-CoV on several levels using inhibitors of clathrin-
mediated endocytosis (classical entry pathway), host membrane
serine proteases (alternative direct entry pathway), as well as
endosomal proteases (downstream endosome fusion). We
detected no significant differences in genomic and subgenomic
Fig. 2 Enhanced replication of lineage 5 MERS-CoV isolates on cultured
cells. Cells were infected at MOI= 0.002 and virus progeny in cell culture
supernatants was quantified by plaque assays. a Vero B4 cells, 24 and 48
hpi; b Calu-3 lung cells, 24 hpi; c Caco-2 colon cells, 24 hpi; d Calu-3 lung
cells grown as air-liquid interface culture, 24 hpi. All infections were
performed with several representative viral isolates per phylogenetic
lineage as documented in Supplementary Table 1. Shown are in a the results
of n= 2 independent experiments with n= 2 MERS-CoV isolates per
lineage and biological triplicates. In b the results of n= 4 independent
experiments overall including all 23 MERS-CoV isolates using biological
duplicates. In c the results of n= 2 independent experiments with n= 2
MERS-CoV isolates per lineage and biological duplicates. In d the results of
n= 2 independent experiments with n= 1 MERS-CoV isolate per lineage
and biological triplicates.; Statistical significance in difference of PFU/ml
between groups was determined by one-way ANOVA, followed by multiple
two-tailed Student´s t-tests between lineage 5 and other lineages. PFU,
plaque forming units; hpi, hours post infection.
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RNA quantities among all virus lineages 1 and 4 h post binding
(Fig. 5). Chemical blocking of virus entry revealed that all four
lineages had entered into the stage of early subgenomic RNA
transcription by 4 h post adsorption, without discernible differ-
ences in transcription levels.
Virus neutralization by anti-MERS-CoV-positive human and
dromedary camel sera. Because neutralizing antibodies may act
via proteins or domains other than the spike N-terminus and
RBD, we tested serum neutralization based on a highly sensitive
plaque reduction neutralization assay on live viruses. All virus
isolates are neutralized with equal efficiency by human (N= 2)
and dromedary camel (N= 3) sera as summarized and referenced
in Supplementary Table 2.
Early viral replication. Whereas the above experiments used
synchronized infection at high MOI, we also performed multi-
cycle, low MOI replication experiments in which the early phase
of replication is less masked by input viral RNA and the early
onset of transcription may not be discernible from genome
replication26. Calu-3 and Vero B4 cells were inoculated at 4 °C to
ensure that virus particles were attached with equal efficiency to
the cellular receptors and the cell entry process started simulta-
neously. We quantified subgenomic mRNA and genomic RNA
transcription and measured PFU/ml in the supernatant to analyze
putative differences in virus particle formation and egress (Fig. 6).
There was little difference between the amount of N- and geno-
mic transcripts. Virus replication in Calu-3 cells started earlier
than in Vero cells, which may be attributed to the availability of
TMPRSS2 providing an additional entry pathway in Calu-3
cells34. Already from the beginning of detectable replication,
lineage 5 viruses show a higher level of RNA transcription than
the parental lineages 3 and 4. Enhanced infectious virus pro-
duction of lineage 5 was only seen in Calu-3- but not in type I
IFN- and TMPRSS2-deficient Vero B4 cells, which corresponds to
our previous observations (Fig. 2). As experiments up to this
point have largely excluded a role of TMPRSS2-dependent entry,
we suspected the phenotypic difference to be linked to cell-
intrinsic innate immunity and in particular the type I IFN system.
Differences in IFN and cytokine induction. To explore if higher
replication is accompanied by higher cytokine induction, we
infected Calu-3 cells with two viruses of each phylogenetic lineage
in a single-cycle infection for 12 h and analyzed the mRNA
expression levels of a set of immune-related genes. We chose
IRF3-regulated genes IFNB1 and IFNL1, NFkB-regulated genes
CCL5 and TNFa, as well as the IFN-stimulated gene (ISG) MX1.
To enable single-cycle virus infection, cells were infected at
MOI= 2 (Fig. 7a). Also under these conditions, the two lineage 5
isolates used in the experiment replicated to a higher level than
the members of lineage 3 and 4. Despite higher replication
putatively upregulating ligands for innate immune sensing such
as dsRNA, lineage 5 induced significantly lower levels of IFN and
CCL5 mRNA compared to isolates pertaining to lineage 3 and 4
(Fig. 7b). Reduced IFNB1 and IFNL1 mRNA expression levels in
lineage 5 infected cells might be a result of a more effective viral
nucleic acid sequestration from pattern recognition receptors
(PRRs) recognition or may reflect an active block of the innate
Fig. 3 Lineage 5 outcompetes a parental virus strain of lineage 3 in an in vitro fitness competition assay. Calu-3 cells were infected in duplicates with
10,000 PFU containing the indicated ratios of a lineage 3: lineage 5 virus isolate at the time of initial infection (p0). Ca 1,000–10,000 PFU were transferred
in five subsequent passages. a At p0 and p5, viral RNA was isolated from the inoculum/supernatant and two RT-PCRs covering two SNP that discriminate
lineage 3 and lineage 5 were performed. RT-PCR amplicons were subjected to Sanger sequencing to visualize shifts in sequence composition. Data of one
representative experiment is shown b the average peak heights in sequencing chromatograms at each SNP were analyzed using the ChromatQuantitator
server and compared between p0 and p5 populations. nt, nucleotide; p, passage.
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immune activation by viral antagonists35. Immune gene mRNA
induction, in general, seemed to be highest with lineage 3 strains.
IFN sensitivity. Previous studies have shown that MERS-CoV
EMC is highly sensitive towards type I IFN pretreatment26. To
analyze IFN sensitivity among the different MERS-CoV lineages,
we compared virus replication in Calu-3 cells pretreated with
IFN-I for 16 h. We monitored virus replication under low unit
IFN concentrations that induce mainly an upregulation of cellular
helicases (2.5 units IFN), as well as under IFN concentrations
high enough to induce a full antiviral state by transcriptional
upregulation of ISGs (25 units).
Fig. 4 Lineage-specific MERS-CoV spike proteins show no difference in host cell entry and DPP4 binding capacity. a–c rhabdoviral particles harboring
MERS-CoV spike proteins of the EMC isolate, lineage 3, lineage 4, and lineage 5, VSV-G (positive control), or eGFP (negative control) were inoculated onto
TMPRSS2-expressing Calu-3, Caco-2, and TMRPSS2 negative Huh7 cells. Transduction efficiency was quantified at 18 h post transduction by measuring
the activity of virus-encoded luciferase in cell lysates. Transduction mediated by EMC spike protein was set as 100%. The means of n= 3 individual
experiments performed in biological quadruplicates are shown; error bars indicate SEMs. Statistical significance was analyzed by paired two-tailed Student
´s t-tests. d 293 T cells untransfected or transfected to express MERS-CoV lineage-specific spike proteins or empty expression vector (pCG1) were
detached and incubated with human Fc-tagged, soluble DPP4 (solDPP4-Fc), diluted 1:50, 1:200, and 1:1,000, and an Alexa Fluor 488-conjugated
antihuman antibody before DPP4 binding was quantified by flow cytometry. For normalization, the binding of solDPP4-Fc (1:200) to EMC spike was set as
100%. For background subtraction of samples incubated with Alexa Fluor 488-conjugated antibodies only (control) was performed for each sample. EMC
spike carrying the I529T SNP was included as an internal control, since this SNP has been previously shown to exhibit reduced DPP4 binding21. Shown are
the normalized data of two independent experiments. Bars indicate mean and SEM. eGFP, enhanced green fluorescent protein; VSV-G, vesicular stomatitis
virus glycoprotein; DPP4, dipeptidyl-peptidase 4.
Fig. 5 All tested MERS-CoV lineages show similar host cell entry. Calu-3 cells were infected in duplicates with one virus isolate of each phylogenetic
lineage (EMC, lineage 3, lineage 4, and lineage 5) at MOI= 1 in the presence or absence of CoV entry inhibitors. Entry inhibited samples were preincubated
for 1 h with a cocktail of 25 µM Cathepsin L inhibitor, 25 µM Pitstop II, and 100 µM Camostat. The inhibitor cocktail remained on the cells during the whole
course of infection. To allow for a synchronized virus entry, virus attachment was performed at 4 °C for 1 h, followed by four washing steps with PBS. After
virus attachment, infected Calu-3 cells were either immediately lysed (0 hpi), or incubated at 37 °C for 1 or 4 h. Total RNA was isolated from lysed cells and
viral genomic RNA (ORF1a) and subgenomic N mRNA (sgmRNA N) was quantified by q-RT-PCR and normalized to the housekeeping gene TBP. The
inoculum of each phylogenetic lineage was back-titrated by plaque assay to confirm that highly similar amounts of infectious particles were used to infect
the cells. PFU, plaque forming units; sgmRNA N, subgenomic nucleocapsid mRNA; ORF, open reading frame; hpi, hours post infection.
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As expected36, replication of the reference strain EMC was
already suppressed by low-level IFN pretreatment. Lineage
3 strains showed similarly high sensitivity, while 2.5 units of
IFN did not detectably suppress lineage 4 and lineage 5 strains
(Fig. 8). These results indicate that MERS-CoV lineages may
differ in their ability to escape innate immune sensing, with a
tendency for lineage 4 and 5 viruses to exhibit a more efficient
escape under low unit IFN treatment. Twenty-five units of IFN
markedly reduced virus replication of all lineages. The reduction
of replication caused by this dose was lower for lineage 5 than
strains pertaining to lineage 3 and 4 (6.5-fold versus 23- and 18-
fold, respectively).
Influence of IFN action via the JAK/STAT signaling pathway.
To investigate if differences in virus replication are linked to viral
suppression of IFN-signaling, we infected Calu-3 cells in the
presence of the JAK/STAT inhibitor Ruxolitinib (Invivogen)
(Fig. 9a), and compared virus replication in MERS-CoV
Fig. 6 Subgenomic nucleocapsid RNA, ORF1a, and PFU quantification at early stages of infection. a Calu-3 and b Vero B4 cells were infected at an MOI
of 0.002 with one virus isolate of each phylogenetic lineage in biological duplicates for each indicated time point in n= 2 independent experiments. At the
indicated time points, cell culture supernatant was harvested and subjected to virus quantification by plaque assay. Infected cells were lysed and total RNA
was isolated and subjected to quantification by q-RT-PCR of sgmRNA N and ORF1a RNA, normalized to the housekeeping gene TBP, and the amount of
RNA at 0 hpi. Shown are the combined data of two independent experiments. Statistical significance of variance in virus replication between groups was
analyzed by one-way ANOVA. Significant differences were found for sgmRNA N (in a) Calu-3: **; p= 0.0026; in b) Vero B4: *; p= 0.0276), for ORF1a
RNA (in a) Calu-3: **; p= 0.0035; in b Vero B4: *; 0.0418) and for PFU/ml in Calu-3 (*; p= 0.0139) PFU, plaque forming units; sgmRNA N, subgenomic
nucleocapsid mRNA; ORF, open reading frame.
Fig. 7 Lineage 5 MERS-CoV strains show reduced immune gene induction. Calu-3 cells were infected with n= 2 isolates of each phylogenetic lineage
with a high multiplicity of infection (MOI= 2) for subsequent quantitative real-time RT-PCR (q-RT-PCR) analysis of key immune genes. a Infectious virus
production at 12 hpi was quantified by plaque assay. Shown are the results of two independent experiments with biological duplicates of n= 2 virus
isolates, with bars indicating the mean and error bars indicating SD. b Immune gene induction as quantified by q-RT-PCR on lysed Calu-3 cells 12 hpi,
expressed as fold induction over the noninfected control cells, normalized to the housekeeping gene TBP. The mean mRNA inductions of biological
duplicates of n= 2 independent experiments with n= 2 virus isolates per lineage is shown with bars indicating the mean and error bars indicating SD.
Statistical significance of differences in virus replication and fold inductions between lineage 5 and lineage 3 or 4 were analyzed by two-tailed, unpaired
t-tests. PFU, plaque forming units; IFNB1, interferon beta 1; IFNL1, interferon lambda 1; CCL5, C-C motif chemokine ligand 5; TNFa, tumor necrosis factor-
alpha.
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susceptible cells carrying an IFN-alpha and -lambda receptor
double knock-out (T84 cells, Fig. 9b). Whereas control experi-
ments confirmed the higher replication levels of lineage 5, both
approaches to IFN-signaling inactivation caused lineage 5 strains
to only lose a part of their replicative prominence. Overall, lineage
5 strains retained a significantly higher replication level than
strains pertaining to lineage 3 and 4, suggesting that differences in
IFN-signaling antagonism alone do not explain the observed
differences.
Increased replication of lineage 5 MERS-CoV may not be
determined by distinct mutations in previously described IFN
antagonists PLP, p4a, p4b, and p5. In order to explore which
amino acid changes might be responsible for the observed
increase of replication of lineage 5 isolates, we analyzed the amino
acid divergence between virus isolates used in this study. We
screened alignments for amino acid exchanges that are shared in
isolates belonging to lineage 5 from 2015 and 2017 but absent in
isolates of other phylogenetic lineages. In total, 16 amino acid
exchanges were exclusively identified in lineage 5 isolates (Sup-
plementary Table 3, highlighted in bold). Due to the phenotypic
implication with IFN antagonism, we focused on amino acid
exchanges in previously described IFN antagonists. We identified
several lineage 5-specific mutations in nsp3 (A187V, A192V,
A383T, E982A, A1150V, M1266I, and T1573I), but found no
amino acid exchanges in the nsp3 papain-like protease (PLPro)37.
There was a single amino acid exchange (A383T) in the nsp3
macrodomain that is thought to influence IFN antagonism in
SARS- and related CoVs by an unknown mechanism38,39.
Protein 4a and protein 5 are completely conserved between the
three MERS-CoV phylogenetic lineages. We identified one
lineage 5-specific amino acid exchange in protein 4b (p4b) at
position 6 (M6T). Deletion of p4b has been shown to increase
IFN induction in the context of virus infection40. We, therefore,
employed our reverse genetics system41 to generate a p4b M6T
mutant virus. However, recombinant wild-type rEMC-CoV and
rEMC-p4b-M6T viruses did not differ in replication (Supple-
mentary Fig. 5).
Replication phenotype in models of the human and camel
respiratory tract. Finally, to more closely reflect virus replication
in the human respiratory tract, we infected differentiated human
airway epithelia (HAEs) with two representative isolates from
each phylogenetic lineage. According to our previous
observations26, we sampled supernatants exclusively from the
apical site of differentiated HAE and quantified virus progeny
every 24 h for four subsequent days. Lineage 5 isolates reached
average titers up to 15-fold higher compared to lineage 3, lineage
4, and the EMC reference strain, with significant differences at 24
and 48 hpi (Fig. 10a). To provide a model of infection that most
closely resembles infection of the human lung, we performed ex-
vivo infections in human lung explants, derived from patients
Fig. 8 Lineage 5 MERS-CoV isolates show decreased IFN sensitivity. Calu-3 cells were incubated for 16 h with 2.5 or 25 units type-I interferon (IFN) prior
to infection at MOI= 0.002 with MERS-CoV isolates of the indicated lineages. Inoculum and virus progeny in culture supernatants were quantified by
plaque assay 24 hpi. Infections were performed in biological triplicates with n= 2 virus isolates per lineage and the experiment was repeated three times.
Shown is the mean PFU/ml of n= 3 independent experiments with bars indicating the mean and error bars indicating SD. Statistical significance of
differences in virus replication between lineage 5 and lineage 3 or 4 was analyzed by two-tailed, unpaired t-tests. PFU, plaque forming units; IFN, interferon.
Fig. 9 Replication of MERS-CoV isolates in JAK/STAT signaling inhibited
and IFN receptor knockout cells. Higher replication of lineage 5 MERS-CoV
is additionally linked to IFN action via the JAK/STAT signaling pathway. a
Calu-3 cells were treated with 50 nM of the JAK/STAT inhibitor Ruxolitinib
1 h prior and during the infection with viruses of the indicated phylogenetic
lineages. Virus progeny in the culture supernatant was quantified by plaque
assay at 24 hpi. Infections were performed in biological duplicates with
n= 2 virus isolates per lineage and the experiment was repeated two times.
Statistical significance of differences in virus replication between lineage 5
and lineage 3 or 4 or EMC was analyzed by two-tailed, unpaired t-tests. b
T84 wt and type I and III IFN receptor knockout cells (IFNAR/IFNLR KO
cells) were infected with viruses of the indicated phylogenetic lineages and
virus progeny in the supernatant was quantified by plaque assay at 24 hpi.
The infections were performed in biological duplicates with n= 2 virus
isolates per phylogenetic lineage and the experiment was repeated two
times. Statistical significance of differences in virus replication between
lineage 5 and lineage 3 or 4 was analyzed by two-tailed, unpaired t-tests.
PFU, plaque forming units; JAK, Janus kinase; STAT, signal transducer and
activator of transcription; IFN, interferon; IFNA/LR KO, IFN-alpha- IFN-
lambda-receptor double knockout; wt, wildtype.
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that have undergone lung resection. We used one representative
virus isolate per phylogenetic lineage to infect lung explants
derived from three different donors (Fig. 10b). Supernatants of
infected lung explants were harvested at 16, 24, 48, and 72 hpi.
Similar to HAEs, lineage 5 titers were up to fivefold higher
compared to titers of lineage 3, lineage 4, and the EMC reference
strain, with significant differences at 24 and 48 hpi (Fig. 10b).
Higher ex-vivo replication of lineage 5 viruses was confirmed by
immunofluorescent analysis of infected lung explants (Fig. 10d).
We quantified the area staining positive for MERS-CoV infection
in three lung explants, derived from three donors, and found
averages of infected areas to be highest in samples infected with
MERS-CoV lineage 5, at 24 hpi (Fig. 10e). We next infected well-
differentiated Bactrian camel airway epithelium cells with two
representative isolates of each phylogenetic lineage. We found
lineage 5 MERS-CoV isolates to show significantly increased virus
Fig. 10 Growth kinetics of MERS-CoV isolates in models of the human and camel respiratory tract. a Replication on primary human airway epithelium
(HAE) of a single donor. Two isolates of each phylogenetic lineage were used for infection in biological triplicates. Virus progeny in apical washes was
quantified every 24 h by plaque assay. Statistical significance in difference of PFU/ml between lineage 5 and other lineages was determined by one-way
ANOVA and two-tailed Student´s t-test for each time point individually. Statistically significant differences in PFU/ml determined by one-way ANOVA
corrected for multiple comparisons using the Tukey method were found at 24 hpi (lineage 5 vs. lineage 3: *; p= 0.0274; lineage 5 vs. EMC: *; p= 0.0301);
at 48 hpi (lineage 5 vs. lineage 3: *; p= 0.0248; lineage 5 vs. lineage 4: *; p= 0.0398); at 72 hpi (lineage 5 vs. lineage 3: **; p= 0.0095; lineage 5 vs.
lineage 4: *; p= 0.0190) and at 96 hpi (lineage 5 vs. lineage 3: ****; p < 0.0001; lineage 5 vs. lineage 4: *; p= 0.0123; lineage 5 vs. EMC: **; p= 0.0050) b
Replication of MERS-CoV isolates on ex vivo lung explants, derived from n= 3 different patients that have undergone lung resection. One isolate of each
phylogenetic lineage was used for infection in biological triplicates for each explant and virus progeny in the supernatant was quantified by plaque assay.
Differences in PFU/ml between lineage 5 and other lineages was tested for significance using the two-sided Kruskal–Wallis test. Statistically significant
differences in PFU/ml were found at 16 hpi (lineage 5 vs. EMC: **; p= 0.0024; lineage 5 vs. lineage 4: **; p= 0.0012), at 24 hpi (lineage 5 vs. EMC: ***;
p= 0.0006; lineage 5 vs. lineage 3: **; p= 0.0080; lineage 5 vs. lineage 4: ****; p < 0.0001), at 48 hpi (lineage 5 vs. EMC: **; p= 0.0064; lineage 5 vs.
lineage 3: **; p= 0.0034; lineage 5 vs. lineage 4: ****; p < 0.0001) and at 72 hpi (lineage 5 vs. lineage 3: **; p= 0.0029; lineage 5 vs. lineage 4: ****;
p < 0.0001) c Replication of MERS-CoV isolates on well-differentiated primary Bactrian camel airway epithelium. Two isolates of each phylogenetic lineage
were used for infection in biological triplicates. Virus progeny in apical washes was quantified every 24 h by plaque assay. Statistical significance in
difference of PFU/ml between lineage 5 and other lineages was determined by one-way ANOVA and two-tailed Student´s t-test for each time point
individually. Statistically significant differences in PFU/ml were found at 72 hpi (lineage 5 vs. lineage 3: *; p= 0.0222; lineage 5 vs. lineage 4: *; p= 0.0266
and at 96 hpi (lineage 5 vs. lineage 3: *; p= 0.0144; lineage 5 vs. lineage 4:*; p= 0.0244). d Immunofluorescent analysis of MERS-CoV lineages replication
in ex vivo human lung tissue. Explants from n= 3 different patients were infected with one MERS-CoV isolate of each lineage for 24 h. Histological sections
were probed with MERS-CoV nucleocapsid antibody (green), nuclei were counterstained with DAPI (blue), and tissue structure was visualized by
differential interference contrast. Scale bar represents 20 µM. e MERS-CoV replication quantified by immunofluorescent analysis. Values represent the
area (in µm2) of positive-infection, determined by nucleocapsid immunofluorescent signal in n= 3 infected lung explants at 24 hpi, measured in biological
duplicates. The complete piece of each lung explant was analyzed for quantification. The positive-infected area of each respective isolate was normalized to
the total lung tissue area and the value obtained for the EMC strain-infected lung tissue. Statistical significance in a quantified infected area between
lineage 5 and EMC was analyzed by two-tailed, unpaired t-tests. Scale bar= 20 µm. PFU, plaque forming units.
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titers at 48 and 72 hpi (Fig. 10c). This indicates that increased
replication of lineage 5 seems to be independent of whether the
virus replicates in human or camel tissue.
Discussion
The present study demonstrates that a newly emerged genetic
lineage of MERS-CoV has higher replicative fitness and causes a
lower level of IFN and cytokine induction than previously cir-
culating strains. An example of recombination between cor-
onavirus lineages that gave rise to a more pathogenic strain has
already been provided by the cases of feline coronaviruses and
avian infectious bronchitis virus42,43. To our knowledge, the
present study is the first to demonstrate a phenotypic change
through recombination in a CoV infecting humans. Its occur-
rence in MERS-CoV is particularly relevant from a public health
perspective as the current human-to-human transmission rate
during sporadic MERS-CoV outbreaks is close to the critical
threshold for sustained transmission (R0= 0.6–1)6,7. Since 2015,
lineage 5 was highly prevalent in sampled dromedary camels and
humans in Saudi Arabia19,20, and caused a major outbreak in
South Korea14–17. This upsurge triggered speculations as to the
transmissibility or fitness of the novel virus variant19,20. Never-
theless, the phenotype of these viruses, as opposed to viruses
circulating earlier, has never been studied. The present study
provides a first comprehensive phenotypic assessment of lineage 5
isolates, showing increases in replicative fitness over previously
circulating lineages.
The in vitro and ex vivo cell culture models used in our study
may not necessarily reflect virus excretion in vivo, but the
observed increase in fitness in these models agrees with epide-
miological trends over several years, in a large geographic region.
Even slight increases in replication may have a profound long-
term influence on pathogen fitness in the host population. As the
increase in replication was also observed in human-derived sys-
tems, increased virus shedding by lineage 5 in humans is con-
ceivable. Because the transmitted virus dose is positively
correlated with the rate of adaptive evolution, lineage 5 may pose
an increased risk of human adaptation when transmission chains
occur in nosocomial outbreaks44,45.
The here reported functional diversity of circulating MERS-
CoV on the Arabian Peninsula is somewhat surprising given that
earlier studies found little indication for phenotypic differences
between viral lineages17,24,46. A study of African MERS-CoV
isolates found functional diversity12 that could be attributed to
deletions in ORF4b encoding a suppressor of RNAse L that acts
via an active phosphodiesterase function27,40. However, all
MERS-CoV isolates used in this study have a full gene repertoire
thus providing little angle to link changes of phenotype to single
viral proteins. Our data indicate that the increased fitness of
MERS-CoV lineage 5 does not result from changes affecting viral
entry and is unlikely to be based on an altered interference with
IFN-signaling. Differences in IFN sensitivity and ISG induction
may be secondarily caused by the primary differences in cytokine
induction.
Multiple viral proteins have been associated with the mod-
ulation of IFN and cytokine induction in MERS- and related
CoVs infected cells, including nsp1, nsp3, nsp14, nsp15, nsp10/
16, p4a, and p4b29,30,38,40,47–52. Among the present MERS-CoV
lineages most of these proteins are either fully conserved (nsp16,
ORF4a, and ORF5), conserved in functional domains (nsp3
PLPro and macrodomain, nsp14 N7-MTase domain, and nsp15
EndoU domain) or show amino acid substitutions unlikely to
affect protein function mediated by changes in polarity or charge,
e.g., F158V in nsp1 (Supplementary Table 4)50,51,53,54.
We particularly focused on amino acid positions in viral pro-
teins for which structural data are available (PLPro in nsp3) and
on proteins uniquely attributed to IFN antagonism in MERS-CoV
(p4a and p4b). The PLPro in nsp3 of most CoVs encodes for a
deubiquitinating domain, which seems to counteract the antiviral
function of ISG15, and importantly, the transcriptional activity of
IRF3, antagonizing IRF3-mediated induction of IFNs, and cyto-
kines downstream of virus sensing48,49,55–57. The second motif in
nsp3, the macrodomain, may further contribute to nsp3-mediated
immune antagonism in SARS- and related CoVs by its ADP-
ribose-1′-phosphatase domain that seems to decrease IFN and
ISG induction in infected cells by a yet unknown mechanism38.
However, all divergent amino acids lay outside of the macro-
domain and described functional residues of PLPro37,58. MERS-
CoV accessory protein 4a antagonizes IFN induction by binding
to dsRNA and inhibiting MDA5 activation, possibly by binding
to its activator PACT29,59. However, no lineage-specific amino
acid exchanges are present in p4a of lineage 5 MERS-CoV. There
was one potentially relevant exchange in p4b, a functional
antagonist of RNase L. We tested the effect of this exchange by
introducing it into a MERS-CoV reference strain via reverse
genetics41. However, the change did not influence the
replication level.
It is conceivable that additive mutations combined from donor
lineages by recombination may cause the fitness increase. Fitness-
increasing secondary mutations could also have occurred after the
recombination event. There is some evidence from our data that
members of the parental lineage 4 show an attenuated cytokine-
based immune response, but these viruses do not show increased
fitness overall. Complementing mutations in the recombinant
virus could be mapped by shuffling of gene portions through
reverse genetics. This may help to understand whether and how
cooperating mutations may have been assembled into one gen-
ome following recombination, and how the recombinant virus
phenotype was selected for. Mapping those causal mutations to
functional domains within the viral genome might help to
understand which viral proteins contribute to the pathogenicity
of newly emerging MERS-CoV.
Based on the present study, we can only resolve the mechanism
of fitness increase to the level of different compartments of cel-
lular immunity, identifying cytokine and IFN induction as a
discriminative trait. It is a limitation that deeper mechanistic
investigation cannot be provided. We note that the observed
differences in virus–host interaction may originate outside the
direct infection sensing and IFN induction mechanisms so that
changes in IFN and cytokine induction, as well as the partial
differences in IFN sensitivity, might be collateral effects.
Our study is limited in that we cannot provide experimental
data on the replication phenotype of MERS-CoV isolates circu-
lating later than 2017. Given that lineage 5 MERS-CoV remained
the dominant lineage in dromedary camels through 201819, it
seems unlikely that changes to its relevance in humans have
occurred. Recent declines in case notification and full genome
sequence deposition might be caused by the COVID-19 pandemic
that has absorbed a lot of surveillance capacities. Moreover, it
should be noted that the observed increased replication of lineage
5 MERS-CoV does not implicate virus selection in humans.
Analyses of viral populations have led to the conclusion that
human-to-human transmission does not play a relevant role in
MERS-CoV evolutionary dynamics, and selection therefore will
have taken place in the animal reservoir60. However, the reduced
induction of cytokine expression is compatible with the selection
of lineage 5 in dromedary camels as immune sensors and
appending signal transduction cascades triggering cytokine
induction are conserved among mammals. Our experiments
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using differentiated camelid airway cultures indeed confirm a
replicative advantage for lineage 5 viruses that is similar to
replication in human cells. Selection for virulence or immune
escape in dromedary camels may thus involve a collateral benefit
for the virus once transmitted to humans. In light of an ongoing
SARS-CoV-2 pandemic, the emergence and epidemiological
dominance of a more replicative strain of MERS-CoV warrants
an increased surveillance of circulating MERS-CoV strains.
Methods
Viruses. All virus stocks have been primarily isolated from respiratory samples,
obtained from Saudi Arabian patients diagnosed with MERS between March 2014
and November 2015. All patient samples were obtained for the purpose of outbreak
investigations by the KSA Ministry of Health and were thus exempt from insti-
tutional review board oversight. A description of the study conditions is provided
in ref. 25. Samples for the present study were utilized without knowledge or usage of
person-related data. Samples with a q-RT-PCR CT value higher than 25 were
selected for primary virus isolation as described in ref. 25. Successful primary
isolates were used for high titer stock production in Vero B4 cells and were con-
centrated using Vivaspin columns (100,000 MWCO PES membrane; Sartorius)
upon reaching maximal cytopathic effect after daily monitoring. All stocks were
quantified using plaque titration as described below.
Virus sequence analysis. Viral RNA of 22 passage two virus stocks was extracted
using the Machinery and Nagel viral RNA kit. Viral RNA was subjected to cDNA
synthesis using the SuperScript® One-Cycle cDNA Kit (Invitrogen) according to
the manufacturer’s protocol. cDNA was fragmented and supplemented with
adapter sequences using the Nextera® XT DNA Library Prep (Illumina), subse-
quently processed with the MiSeq Reagent Kit v3 (Illumina) and subjected to NGS
on a MiSeq™ System (Illumina), all according to the manufacturer’s protocol. Using
Geneious software, version 9.1.8, contigs were assembled by mapping reads to the
EMC genome (Genbank ref.: JX869059). Assembled full genomes have been
deposited to NCBI GenBank under the accession numbers MN481964 to
MN481978.
Phylogeny and recombination analysis. Phylogenies of whole-genome and
subgenomic sequence alignments were estimated by the maximum-likelihood
approach, implemented in IQtree, version 2.0.3 (whole genome alignment)61, or
RaxML, version 8.0.0 (subgenomic genome alignments). Whole-genome phylo-
genies were estimated with a transition model and unequal base frequency
(TIM+ F+ I) and 1,000 bootstrap replicates. RaxML trees were estimated with a
general time-reversible (GTR) model of nucleotide substitution with estimated
gamma-distributed rate variation and a proportion of invariant sites. About 10,000
bootstrap replicates were run. Input alignments of whole-genome and subgenomic
sequences comprising the outer and inner nonrecombinant segments were aligned
by implementing ClustalW in Geneious software, version 9.1.8.
For detailed recombination analysis, we performed a BootScan analysis with
500 bootstraps in SimPlot, version 3.5.1., with a sliding window of 5,000 and
200 bp steps.
General cell culture procedures. All cells were maintained in Dulbecco’s Mod-
ified Eagles Medium (DMEM) at 37 °C, 5% CO2 as described earlier25. For virus
titration, Vero B4 cells were used. For infection studies Vero B4 (DSMZ-AC33),
Calu-3 (ATCC HTB-55) and Caco-2 (ATCC HTB-37), T84 (ATCC-CCL-248), and
T84 IFN alpha and lambda receptor double knockout cells were used. For polar-
ization, Calu-3 cells were seeded on transwell inserts (Greiner Bio, pore size
0.4 µm) and initially cultivated under liquid-liquid conditions for 3 days. Subse-
quently, cells were transferred to the ALI condition with basolateral medium
exchange every 2 days for 14 days. Prior to infection, complete polarization was
confirmed by transepithelial electrical resistance measurement. For VSVpp trans-
duction studies, 293 T, Caco-2, Calu-3, and Huh-7 cells were used and maintained
as described above. Well-differentiated human and Bactrian camel airway epithelial
cell cultures were generated and maintained as described in ref. 62. In brief, primary
human tracheobronchial epithelial cells were isolated from patients (>18 years old)
undergoing bronchoscopy or pulmonary resection at the Cantonal Hospital in St.
Gallen, Switzerland, in accordance with ethical approval (EKSG 11/044, EKSG 11/
103, KEK-BE 302/2015). Bactrian camel tracheobronchial epithelial cells were
isolated from postmortem tissue obtained from the veterinary hospital of the
University of Bern. To generate well-differentiated AEC cultures, cryopreserved
cells were thawed and expanded into collagen type I-coated flasks in Bronchial
Epithelial Growth Media (BEGM,) medium, followed by seeding into collagen type
IV-coated porous inserts (6.5 mm radius insert, Costar, Corning) in 24-well plates.
After seeding, cells were grown at a liquid-liquid interface for 2–3 days in a BEGM
medium. Once cells reached confluency, cultures were air-lifted to establish an ALI
to allow for cellular differentiation using the ALI medium. For Bactrian camel AEC
cultures, the EGF concentration in the ALI medium was increased to 5 ng/ml. Both
human and Bactrian camel AEC cultures were maintained at 37 °C in a humidified
incubator with 5% CO2 and the basolateral ALI medium was changed every
2–3 days.
Lung explants infection, culture procedure, and immunofluorescent analysis.
Lung explants were obtained from patients undergoing lung resection. Written
informed consent was obtained from all patients and the study was approved by
the ethics committee at Charité clinic (project EA2/079/13). For each experiment
tumor-free human lung tissue was cut into small pieces (weight approx. 0.1–0.2 mg
per piece) and incubated in RPMI 1640 medium at 37 °C with 5% CO2. After
overnight incubation lung organ cultures were inoculated with 1x10e5 PFU of virus
for 1.5 h under shaking conditions followed by one washing step with phosphate-
buffered saline (PBS) to remove the excess virus. Lung tissue was incubated for up
to 72 hpi in RPMI 1640 medium containing 10% fetal calf serum and 2 mM L-
glutamine. For growth curve analysis supernatants of infected lung tissue were
harvested at 0, 16, 24, 48, and 72 hpi and supernatants were titrated on Vero E6
cells by standard plaque titration assay.
For immunofluorescent analysis, processing of human lung tissues was
performed as described in ref. 63. In brief, MERS-CoV infected tissue samples were
fixed in 3% paraformaldehyde twice for 24 h. Samples were subjected to anti-
MERS-CoV nucleocapsid primary antibody (Sino Biological, China) detection
overnight at 4 °C and labeled with a secondary antibody Alexa Fluor 488
(Invitrogen). Nucleus counterstaining was performed with DAPI (Sigma Aldrich).
Immunofluorescence spectral confocal microscopy was conducted using an LSM
780 [(objectives: Plan Apochromat 63x/1.40 oil DIC M27), Carl-Zeiss]. Based on a
spectral image lambda stack, linear deconvolution of tissue autofluorescence and
overlapping spectra of fluorochromes was performed using ZEN 2012 software
(Carl-Zeiss). Each image shows a maximum fluorescence intensity projection of a
z-stack representing the entire 10 µm section. To reveal lung and cell morphology,
images were combined with Differential Interference Contrast (DIC). All image
sets were acquired using equal configurations. Images were processed using ZEN
2012 (Carl-Zeiss)and ImageJ software (http://imagej.nih.gov/ij/). Quantification of
Alexa Fluor 488 signal intensity was performed using ZEN 3.1 (blue edition; Carl-
Zeiss). Briefly, stained human lung slides were scanned using Axio scan.Z1 (Carl-
Zeiss) followed by digital image segmentation of positive-infected areas in µm2 and
normalization to the total area of the lung slices, measured by autofluorescence of
the lung tissue.
Virus infections. Vero B4 and Caco-2 cells were seeded at 1.5x10e5 cells/well,
Calu-3 cells at 3x10e5 cells/well, and T84 cells at 2x10e5 cells/well, all in composite
DMEM in 24-well plates 16 h prior to infection. Cultured cells (Vero B4, Calu-3,
Caco-2, and T84 cells) were infected with passage two MERS-CoV stocks diluted to
the desired MOI in OptiPro for 1 h at 37 °C. Primary airway epithelia (AEs) were
infected with 4,000 PFU in Hanks Balanced Salt Solution (HBSS) for 1.5 h. Sub-
sequently, cells were washed three times with PBS or HBSS for AEs, respectively,
and further incubated. At 24 and 48 h, respectively 24, 48, 72, and 96 h for AEs,
supernatants were harvested and viral loads were quantified by plaque titration on
Vero B4 cells as described below. For IFN priming experiments, Calu-3 and Vero
B4 cells were treated 24 h post seeding with either 0, 2.5, or 25 units pan-species
type I IFN (Biochrom) for 16 h prior to infection.
Synchronized infections and virus–host cell entry blocking. For virus cell entry
experiments, Calu-3 cells were seeded 16 h before infection in a 24-well format at a
seeding density of 3x10e5 cells/well. One hour prior to virus infection, cells were
washed twice with PBS and treated with composite DMEM without FCS, con-
taining only DMSO (no inhibitors) or DMEM without FCS, containing a triple
combination of previously described CoV entry inhibitors resolved in DMSO
(inhibitor samples). Cathepsin L inhibitor MDL28170 and Pitstop II (both Sigma-
Aldrich) were used at a final concentration of 25 µM, Camostat mesylate (Sigma-
Aldrich) was used at a final concentration of 100 µM. Calu-3 cells infection was
performed on ice and the cells were immediately put on 4 °C for 1 h after pipetting
virus dilutions onto the cells to allow for virus attachment for the cells without
receptor-mediated virus entry. Cells were subsequently washed five times with PBS
to remove the majority of unbound virus particles and either immediately lysed (0
hpi samples), or incubated with composite DMEM, with or without the inhibitor
cocktail, for 1 or 4 more hours post infection (1 hpi and 4 hpi samples), prior to
medium removal and cell lysis. RNA isolation of cell lysates and quantitative real-
time PCR was performed as mentioned below.
Plaque titration and plaque reduction neutralization test. Vero B4 cells were
seeded at 1.5x105 cells/well in 24-well plates 16 h prior to titration. A 1:2 mixture of
Avicel (2.4 g/l, FMC BioPolymer) and double concentrated DMEM was used as an
overlay. Four days post infection, cells were washed, fixed, and stained in 6%
formaldehyde solution containing crystal violet. Plaque reduction neutralization
tests (PRNT) was performed as described in ref. 25. In brief, 25 PFU of each isolate
were incubated with serially diluted serum for 1 h at 37 °C, prior to plaque titration.
The following five sera were used for neutralization: Munich-1 (MERS patient,
Germany 2014), SA278 (MERS patient, KSA 2014), Dubai-S1 (dromedary camel,
UAE 2014), Kenia-ILRI (dromedary camel, Kenya 2017), and Pakistan-493 (dro-
medary camel, Pakistan 2017) (Supplementary Table 2).
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Cloning of lineage-specific Spike genes and generation of VSV pseudotype particles
(VSVpp) and transduction of target cells. Previously cloned pCG1 vector carrying
the EMC spike gene was subjected to mutagenesis PCR to accommodate the three
amino acid substitutions specific for lineage 3, lineage 4, and lineage 5 (Supple-
mentary Fig. 3). In the first round of mutagenesis PCR using Phusion polymerase
(Thermo Fisher Scientific), the Q1020R mutation was introduced (all lineages). The
obtained plasmid was then subjected to the second round of mutagenesis PCR,
introducing either L411F (lineage 3) or Q833R (lineage 5). 5´phosporylated pri-
mers were used for mutagenesis PCR. indicated in Supplementary Table 5 with the
underlined nucleotides being the substitutional sequences.
Obtained pCG1 plasmids were used for the production of rhabdoviral spike
proteins pseudotyped vectors, generated according to a previously published
protocol21. Briefly, 293 T cells transfected with pCG1 vectors, carrying EMC-Spike,
MERS-S Q1020R, MERS-S Q1020R/L411F, MERS-S Q1020R/Q833R, VSV-G
(positive control), or empty expression plasmid (negative control) were inoculated
with replication-deficient, VSV-G-trans complemented VSV in which the VSV-G
gene was replaced by eGFP and firefly luciferase, VSV*ΔG (VSV-G)64 that was
kindly provided by Gert Zimmer. After 1 h incubation at 37 °C, the supernatant
was removed, the cells were washed with PBS and a fresh culture medium was
added. In case of spike protein-expressing cells or cells transfected with an empty
expression vector, the medium was supplemented with the VSV-G-neutralizing
antibody I1 (produced from CRL-2700 cell line, ATCC).
For transduction of target cells in 96-well format, the culture medium was
removed and cells were inoculated with 100 µl VSVpp. At 18 h post inoculation
cells were lysed for 30 min at RT in 50 µl Luciferase Cell Culture Lysis Reagent
(Promega) were added. Lysates were transferred into white, opaque-walled 96-well
plates, and activity of virus-encoded luciferase was measured using the Luciferase
Assay System substrate (Promega) and the Hidex Sense plate reader (Hidex).
Quantification of MERS-S binding to DPP4 by flow cytometry. Analysis of S
protein binding to DPP4 was analyzed by flow cytometry employing a previously
published protocol21. In brief, 293 T cells were untransfected or transfected with the
overexpression vector pCG1 either empty or carrying MERS-CoV Spike protein of
clade A (EMC), EMC I529T, lineage 3 (L411F/Q1020R), lineage 4 (Q833R/Q1020R),
or lineage 5 (Q1020R), as well as an empty vector for negative control. At 48 h post
transfection, cells were resuspended in PBS, centrifuged (5 min at 600xg at 4 °C), and
resuspended in PBS containing 1% bovine serum albumin (1% BSA/PBS) for washing.
The cells were centrifuged again and incubated in 1% BSA/PBS containing soluble
DPP4 equipped with a C-terminal human Fc-tag (solDPP4-Fc,1:50, 1:200 and 1:1,000;
ACROBiosystems) at 4 °C in an overhead shaker for 1 h. Afterward, the cells were
pelleted and incubated in 1% BSA/PBS containing an Alexa Fluor488-conjugated
antihuman antibody (1:500; Thermo Fisher Scientific), for 1 h at 4 °C in an overhead
shaker. Subsequently the cells were pelleted, washed with 1% BSA/PBS, and fixed in 4
% paraformaldehyde solution for 20min at room temperature. Prior to analysis via
flow cytometry, the cells were pelleted again and washed with 1% BSA/PBS. Flow
cytometry was conducted on an LSR II Flow Cytometer, with a double gating strategy
(1) Total cells: SSC-A vs. FSC-A and (2) Singlets: FSC-H vs. FSC-A. Quantification of
an Alexa Fluor488 signal was performed in the second gate. Data were further pro-
cessed in the FCS Express 4 Flow research software (De Novo software).
Direct competition assay. Virus stocks of one lineage 5 isolate (Riyadh-1764-
2015) and one lineage 3 isolate (Riyadh-1147-2014) were mixed at two ratios (1:1
and 1:9 lineage 5:lineage 3) and used to infect Calu-3 cells in duplicates at an MOI
0.04 (corresponding to 10,000 total PFU). As a control, a single infection with only
10,000 PFU of the lineage 5 or the lineage 3 isolate was performed. At 24 hpi, 100 µl
of the cell culture supernatants of infected cells were used to inoculate new Calu-3
cells for five subsequent passages. Viral RNA was isolated from each inoculum
(passage 0/p0) and after five passages (passage 5/p5) using the Machinery and
Nagel vRNA kit and three short PCR amplicons were reverse transcribed (SSIII/
Taq one-step kit; Thermo Fisher Scientific) using specific primers (Supplementary
Table 5)The obtained PCR amplicons was sent for Sanger sequencing. For peak
height analysis, the web-based Chromat Quanitator (Mullins lab, University of
Washington) was used and quantified sanger sequencing peak heights were aver-
aged for all duplicates and calculated as a percentile of the total height.
Generation of recombinant rMERS-CoV rEMC-p4b-M6T by red-mediated
recombination A MERS-CoV strain carrying the lineage 5 specific ORF4b M6T
mutation (rEMC-p4b-M6T) was constructed from our cDNA clone by red-
mediated recombination41. We generated the I-SceI-aphAI transfer cassette
containing 5´and 3´ 40 bp homologous hooks to the MERS-CoV EMC genome and
the M6T mutation by Phusion PCR amplification (Thermo Fisher Scientific).
Electroporation of the purified transfer construct and both recombination steps
were performed as described in Muth et al., 201741. Bacterial clones carrying the
correct insert size after first and second recombination were identified by PCR.
Virus rescue from purified full-length SARS-CoV cDNA clones was performed as
described in Muth et al. 201741. In brief, cDNA plasmids were linearized by MluI
digestion, in vitro transcribed, and capped (mMESSAGE mMACHINE T7
Transcription Kit, Thermo Fisher Scientific). In vitro transcripts were
electroporated into BHK-21 cells. 24 and 48 h post electroporation, 1 ml of the
supernatant was transferred to susceptible Vero B4 cells and virus replication was
monitored by quantitative real-time PCR65. Recombinant viruses were harvested
three days post infection. Virus stocks were purified and subjected to full-genome
sequencing on a MiSeq System (Illumina).
Quantitative real-time PCR. For quantitative real-time PCR analysis, total RNA of
MERS-CoV infected Calu-3 cells was harvested at 12 hpi using the Machinery and
Nagel total RNA kit, following the manufacturer’s instructions. A two-step PCR
protocol was used for the quantification of host transcripts. First, cDNA was
prepared from equal molar viral RNA using the iScript™ cDNA synthesis kit (Bio-
Rad), according to the manufacturer’s protocol. Second, cDNA was amplified and
quantified using Taq-polymerase (Invitrogen) and a set of real-time primer and
probes for each transcript under investigation for sgmRNA N and ORF1a RNA
analysis, cells were harvested at 0, 2, 4, 6, 8, 10, 12, and 24 hpi and total RNA was
isolated and subjected to quantitative real-time PCR using the one-step SuperScript
III kit (Invitrogen) with primers published in ref. 65 and ref. 66.
Statistical analysis. Analysis of variance (ANOVA) with Bonferroni’s post hoc
test was used for group-wise comparisons. Unpaired Student´s t-test test was
applied for comparisons of groups. Statistical tests were implemented in GraphPad
Prism, version 8.2.1. All statistical tests were two-tailed and p < 0.05 was considered
statistically significant, with asterisks indicating the degree of significance as fol-
lows: ns P > 0.05; *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001, and ****P ≤ 0.0001.
Reporting Summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
All MERS-CoV genome sequences used in this study are available on GenBank under
accession numbers MN481964 to MN481978 (Supplementary Table 4). Source data
displayed in Figs. 2–10 and Supplementary Figs. 2, 3, and 5 are provided online (source
data file).
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